Interpretation of Microscopic Urinalysis in Pregnancy
In pregnant patients, urinary tract infection should be diagnosed based on urine culture showing ≥10⁵ CFU/mL of a single organism, not on microscopic findings alone; pyuria without bacteriuria does not require treatment, and all pregnant women should be screened with urine culture in early pregnancy regardless of urinalysis results. 1
Key Diagnostic Principles
Urine Culture is the Gold Standard
- Urine culture is mandatory for diagnosing UTI in pregnancy—urinalysis alone is insufficient. 1
- A single clean-catch voided specimen with ≥10⁵ CFU/mL of one bacterial species defines bacteriuria in pregnant women 2
- A single catheterized specimen with ≥10² CFU/mL also meets diagnostic criteria 2, 1
- For asymptomatic bacteriuria, two consecutive voided specimens with the same organism at ≥10⁵ CFU/mL are required 2
Interpretation of Microscopic Findings
White Blood Cells (Pyuria):
- Pyuria alone has only ~50% sensitivity for detecting bacteriuria and should NOT trigger treatment 1
- Pyuria accompanying asymptomatic bacteriuria is NOT an indication for antimicrobial treatment 2
- The presence or absence of pyuria does not change management when culture results are available 1
- Pyuria without bacteriuria (culture-negative) does not require antibiotics 1
Red Blood Cells:
- Hematuria is not a reliable indicator of UTI in pregnancy 3
- Only 2.5% of pregnant women show RBCs on microscopy, with limited diagnostic value 3
Bacteria:
- Visual bacteria on microscopy is less specific than culture 3
- Bacteriuria on microscopy is more specific than pyuria but still requires culture confirmation 4
- Nitrites on dipstick are more sensitive and specific than other components, but culture remains definitive 4
Screening Recommendations
- All pregnant women should be screened with urine culture at least once in early pregnancy (ideally 12-16 weeks gestation) 5, 1
- Screening should occur regardless of symptoms or urinalysis findings 1
- A single screening culture at 16 weeks is considered optimal timing 1
Treatment Indications and Regimens
When to Treat
Treatment is indicated when:
- Urine culture shows ≥10⁵ CFU/mL of a single organism, regardless of symptoms or pyuria 1
- This applies to both asymptomatic bacteriuria and symptomatic UTI 5
Rationale for treating asymptomatic bacteriuria:
- Untreated ASB increases pyelonephritis risk from baseline to 20-35% 2, 5
- Treatment reduces pyelonephritis risk to 1-4% 2, 5
- Treatment reduces preterm birth and low birth weight 5
Antimicrobial Regimens
Duration:
- 4-7 days of antimicrobial therapy is recommended (not single-dose) 5
- The 2019 IDSA guideline upgraded from 3-7 days to 4-7 days based on improved outcomes 5
Preferred agents:
- Nitrofurantoin (avoid near term) 6
- Cephalexin or other cephalosporins 6
- Fosfomycin 4
- Trimethoprim-sulfamethoxazole (avoid first and third trimesters) 6
- Ampicillin should be avoided due to high resistance rates 6
Post-Treatment Follow-Up
- Periodic repeat urine cultures should be obtained after treatment to detect recurrent bacteriuria 2, 1
- Routine post-treatment cultures are recommended for pregnant women (unlike non-pregnant women) 2
Common Pitfalls to Avoid
- Do not treat based on pyuria alone—this leads to unnecessary antibiotic exposure 2, 1
- Do not rely on urinalysis instead of culture—culture is required for all pregnant patients being evaluated for UTI 1
- Do not use single-dose therapy—4-7 day courses are more effective in pregnancy 5
- Do not skip screening—even asymptomatic pregnant women require culture screening 5
- Do not ignore mixed growth—17.2% of cultures show mixed growth indicating contamination; proper midstream collection technique is essential 3
Clinical Algorithm
- Obtain urine culture on all pregnant patients with urinary symptoms or as routine screening in early pregnancy 1
- Interpret culture results:
- Ignore pyuria status when making treatment decisions 2, 1
- Repeat culture 7 days after completing therapy 1
- Continue periodic screening throughout pregnancy after treatment 2